Navigation Links
Video: RE-LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non-valvular Atrial Fibrillation Patients
Date:8/30/2009

RIDGEFIELD, Conn., Aug. 30 /PRNewswire/ -- Boehringer Ingelheim today announced that results from the RE-LY(R) (Randomized Evaluation of Long-Term Anticoagulant Therapy, Warfarin, Compared with Dabigatran) study -- the largest atrial fibrillation (AF) outcomes trial ever conducted(1) (18,113 patients in 44 countries worldwide) -- were presented for the first time at the European Society of Cardiology Congress and published online in the New England Journal of Medicine.(2) The primary objective of RE-LY was to assess the safety and efficacy of the investigational oral direct thrombin inhibitor, dabigatran etexilate against warfarin (titrated to INR 2.0 to 3.0) for the prevention of stroke in patients with non-valvular atrial fibrillation.(1)

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/boehringeringelheim/39821/

The RE-LY study results have shown:

  • Both doses of dabigatran etexilate were non-inferior to warfarin on the primary endpoint of reducing the incidence of stroke (including hemorrhagic) and systemic embolism (p < 0.001)(2)
  • Dabigatran etexilate 150 mg BID was superior to warfarin in reducing the incidence of stroke (including hemorrhagic) and systemic embolism by 34 percent (RR 0.66, 95% CI, 0.53-0.82, p < 0.001)(2)
  • There was no significant difference in the rate of major bleeding for dabigatran 150 mg BID compared to warfarin (3.11 percent/year, 3.36 percent/year, respectively p=0.31)(2)
  • The rate of major bleeding with dabigatran etexilate 110 mg BID (2.71 percent/year) was 20 percent lower compared to warfarin (p=0.003)(2)

Also presented and published today were results in other outcomes from t
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Video: Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Patients
2. Video: AstraZeneca Traveling Exhibit Helps Americans Understand and Manage Bipolar Depression
3. Video: School Nurses Tackle Low Parental Awareness of Meningitis Via Comprehensive National Public Education Campaign
4. Video: Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month
5. Video: Schering-Plough Announces FDA Approval of SAPHRIS(R) (asenapine) for Acute Treatment of Schizophrenia In Adults and Manic or Mixed Episodes of Bipolar I Disorder With or Without Psychotic Features In Adults
6. Video: FDA Approves EMBEDA(TM) For Management of Moderate to Severe Chronic Pain
7. Video: Provectus Pharmaceuticals Updates Shareholders On 2009 Year-To-Date Accomplishments
8. Video: People With Pain, Healthcare Providers Sound Off in First-Ever Online Talk Show About Pain
9. Video: American Dental Association Statement: Food and Drug Administration Action on Dental Amalgam
10. Video: Sodexo Takes on Childhood Obesity in School Cafeterias
11. Video: What Are Those Little Red Bumps?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Rockynol Retirement Community broke ground on ... $11 million project will include the latest in Assisted ... full-service restaurant style dining. , “We are excited to ... Living apartments,” said Kara Hanzie, Rockynol Executive Director during ... care and this investment is proof of our commitment.” ...
(Date:10/20/2014)... Cleveland, Ohio (PRWEB) October 20, 2014 Unveiled ... Affairs’ new Strategic Direction Scorecard conservatively estimates member hospital ROI ... dollar spent on dues, The Center provides $12.50 in value ... ROI is (Member Value – Member Dues)/Member Dues. , ... get at this number and we think the methodology is ...
(Date:10/19/2014)... Hastings and Hastings, a Phoenix personal injury law ... greater Phoenix area and across Arizona reports record demand ... automobile accidents. Statistics have indicated a steady increase in ... such, Hastings and Hastings has seen a steady increase ... have been injured through no fault of their own ...
(Date:10/19/2014)... working in the garment industry for decades, LunaDress’ dress specialists ... one of the company’s top designers, many ladies like prom ... add beauty to them. Chiffon floor length outfits are also ... selection of 2014 long prom dresses. , As a ... in over 20 popular designs. The company intends to meet ...
(Date:10/19/2014)... Stephen T. Greenberg, M.D., with offices in Woodbury, Southampton and ... as one of Long Island’s best cosmetic surgeons. In ... the best provider for Botox injections. Glisten, his Skin & ... best Laser Treatment center on Long Island.* , The voting ... the contest once per day, per IP address. , Stephen ...
Breaking Medicine News(10 mins):Health News:Rockynol Retirement Community Expands Assisted Living Center 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 2Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 3Health News:2014 Long Prom Dresses From LunaDress Now Available In Over 20 Popular Designs 2Health News:Dr. Stephen T. Greenberg – Nominated for the 10th Consecutive Year for One of Long Island’s Best Cosmetic Surgeons for 2015 by the Long Island Press 2
... The medical community has repeatedly warned against plying young children with ... parents seem to care . Certainly not in Australia. ... extractions, dentists in that country say. ,In the ... but to remove all 20 baby teeth. ,"It's ...
... long ago there was a theory doing the rounds that ... autistic individual. This theory was not well received and ... prompted the proponents of the theory to associate the schemingly ... autism? ,Autism is a developmental disability that affects ...
... way for 70-year-old Hakimuddin of Orissa and his three ... after the impoverished man wrote to India's president ... district collector of Bhadrak in Orissa constituted a team ... on the condition of the poor family in Kamalpur ...
... common genetic variation on chromosome 9p21 is linked to a ... new international research study . The findings are published today ... an upcoming printed edition of the journal. ,Researchers ... of suffering a heart attack (myocardial infarction) and a 2.02-fold ...
... (CE-US) after a liver transplant is highly accurate in ... to a recent study. ,The study consisted ... exam after developing fluid in the abdomen and/or unclear ... serious complication in the early post transplant period, caused ...
... University researchers seem to know what makes certain babies prone ... Edinburgh University and the Royal Hospital for Sick Children in ... premature and small babies which expose them to risks of ... of the maternal and child health sciences division, are team ...
Cached Medicine News:Health News:Experts Call for Warning Lables on Fruit Juice to Save Kids' Teeth 2Health News:Diet for Autism 2Health News:Diet for Autism 3Health News:Disabled Orissa Brothers Lives Saved by Timely Intervention 2Health News:Genetic Variation is Linked to Substantial Risk in Heart Attack 2
(Date:10/17/2014)... , October 17, 2014 Investor-Edge ... Inc. (NASDAQ: ARNA ), NPS Pharmaceuticals Inc. ... XOMA ), Momenta Pharmaceuticals Inc. (NASDAQ: ... Free research on these five companies can be accessed ... on Thursday, October 16, 2014, ended on a mixed ...
(Date:10/17/2014)... Oct. 17, 2014  UBM Medica US announces that ... endocrinologists and other clinicians who treat patients with ... effective use of insulin .  ... insulin replacement therapy – daily injections of one ... decline in the function of pancreatic beta cells. Insulin ...
(Date:10/17/2014)... Oct. 17, 2014  China Biologic Products, Inc. ... leading fully integrated plasma-based biopharmaceutical company in ... Company has received approval from the China Food ... of human prothrombin complex concentrate ("PCC") at its ... new coagulation factor production facility for Good Manufacturing ...
Breaking Medicine Technology:Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 2Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 3Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 4Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 5Endocrinology Network Features Special Coverage on Effective Use of Insulin 2Endocrinology Network Features Special Coverage on Effective Use of Insulin 3China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 3
... DIEGO, Nov. 11, 2010 Althea Technologies, Inc., a ... biopharmaceutical and parenteral products, announced today that Rick ...  Mr. Hancock brings twenty-seven years of industry experience and ... company into the future.  Mr. Hancock will lead the ...
... a meeting convened by the U.S. Food and Drug ... took the next step in advancing efforts toward the ... to ensure the safe and effective testing of artificial ... today,s meeting there was a strong consensus among leading ...
Cached Medicine Technology:Althea Technologies Announces Appointment of Rick Hancock as President 2JDRF Clinical Panel Recommends Next Steps for Artificial Pancreas Clinical Testing 2JDRF Clinical Panel Recommends Next Steps for Artificial Pancreas Clinical Testing 3JDRF Clinical Panel Recommends Next Steps for Artificial Pancreas Clinical Testing 4
... to 350 Liters of pure water, Complete, ... of Purified Water,Millipores compact S.D.S. Storage and ... to 350 liters of purified water produced ... maintain consistent purity of stored water, provide ...
... a range of Milli-Q ultrapure water ... quality requirements. Each of the five ... specifically target contaminants detrimental to particular ... and ICP-MS. The systems incorporate a ...
... a range of Milli-Q ultrapure water ... quality requirements. Each of the five ... specifically target contaminants detrimental to particular ... and ICP-MS. The systems incorporate a ...
... Millipore has developed a range ... to match specific water quality requirements. ... systems is designed to specifically target ... as HPLC, molecular biology and ICP-MS. ...
Medicine Products: